All In Biotech

Drug Trial Radar · NCT06588855

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Patients With Moderately to Severely Active Ulcerative Colitis

Last checked: Nov 19, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 350 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

350

Planned (sponsor's estimate)

Start

Dec 11, 2024

Primary completion

Oct 29, 2026

Study completion Jan 30, 2031

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Sep 19, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 16 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO7790121) compared with placebo in participants with moderately to severely active ulcerative colitis (UC).

Conditions

  • Moderately to Severely Active Ulcerative Colitis

Interventions

  • AfimkibartDrug

    Participants will receive afimkibart IV followed by afimkibart subcutaneous SC injection.

  • PlaceboDrug

    Placebo matching IV afimkibart. Placebo matching SC afimkibart.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants with Clinical RemissionTime frame: At Week 12

Locations

168 sites in 29 countries. Site status is shown where the registry gives one.

  • Digestive Health Specialists of the Southeast (Gastroenterology Associates of Dothan) - Dothan

    Dothan, Alabama

  • Mayo Clinic Hospital

    Scottsdale, Arizona

  • Arizona Digestive Health, P.C (ADH)

    Sun City, Arizona

  • Om Research LLC

    Apple Valley, California

  • Valley View Internal Medicine

    Garden Grove, California

  • Gastro Care Associates

    Lancaster, California

  • Stanford Medicine Outpatient Center

    Redwood City, California

  • Peak Gastroenterology Associates

    Colorado Springs, Colorado

  • Hi Tech and Global Research, LLC

    Coral Gables, Florida

  • The Sister Life Research

    Hialeah, Florida

  • LCC Medical Research Institute, LLC

    Miami, Florida

  • Allied Biomedical Research Institute

    Miami, Florida

  • Integrity Trials LLC

    Orlando, Florida

  • Digestive and Liver Center of Florida

    Orlando, Florida

  • Advanced Medical Research Center

    Port Orange, Florida

  • University of South Florida School of Medicine Morsani Center for Advanced Health Care

    Tampa, Florida

  • Guardian Angel Research Center, LLC

    Tampa, Florida

  • Santos Research Center, CORP

    Tampa, Florida

  • Cleveland Clinic Florida

    Weston, Florida

  • Randomize Now, LLC

    Atlanta, Georgia

  • Atlanta Gastroenterology Associates

    Atlanta, Georgia

  • Gastroenterology Associates of Central Georgia

    Macon, Georgia

  • Illinois Gastroenterology Group-Glenview powered by GI Alliance

    Glenview, Illinois

  • GI Alliance - Gurnee

    Gurnee, Illinois

  • Gastro Health Partners, LLC

    New Albany, Indiana

  • Kansas Gastroenterology, LLC under Clinical Trials Network

    Wichita, Kansas

  • One GI: GHP - Gastroenterology Health Partners Louisville

    Louisville, Kentucky

  • Louisiana Research Center - GastroIntestinal Associates

    Shreveport, Louisiana

  • Allied Gastrointestinal Associates, PA

    Flowood, Mississippi

  • Dartmouth-Hitchcock Medical Center-Norris Cotton Cancer Center

    Lebanon, New Hampshire

  • Ellipsis Research Group

    Brooklyn, New York

  • NYU Inflammatory Bowel Disease Center

    New York, New York

  • Weill Cornell Medical College

    New York, New York

  • DiGiovanna Inst for Med Ed&Res

    North Massapequa, New York

  • Queens Village Medical Care

    Queens Village, New York

  • Gastroenterology Group Of Rochester, LLP

    Rochester, New York

  • Charlotte Gastroenterology and Hepatology, P.L.L.C

    Charlotte, North Carolina

  • Omega Research North Carolina, LLC

    Fuquay-Varina, North Carolina

  • Peters Medical Research (PMR), LLC

    High Point, North Carolina

  • Dayton Gastroenterology, Inc.

    Beavercreek, Ohio

Showing 40 of 168 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.